Rafael Kramann, MD, PhD

Rafael Kramann, MD, PhD

RWTH Aachen University, Senior Investigator - Question 2

Kramann (expert in innovative single cell/nuclear RNA-seq and ATAC-seq technologies) and Rosenthal (global leader in the use of targeted mutagenesis in mice to investigate mammalian development, disease and repair) will coordinate and perform Q2 studies.

Kramann is also responsible for the implementation of the training plans.

Profile

https://www.researchgate.net/profile/Rafael-Kramann

Lab

https://www.kramannlab.com/